What to watch with HLA-DQ2 and Wechseljahre?

The combination of HLA-DQ2 (a genetic risk marker for celiac disease) and menopause (Wechseljahre) warrants careful monitoring. During menopause, declining estrogen levels accelerate bone density loss, increasing osteoporosis risk. In HLA-DQ2-positive women with celiac disease or gluten sensitivity, undiagnosed gluten exposure can cause malabsorption of calcium and vitamin D, further compromising bone health. Additionally, hormonal fluctuations may affect intestinal permeability and inflammatory responses, potentially worsening gastrointestinal symptoms. However, no robust clinical studies directly link HLA-DQ2 to menopause-specific symptoms. Practical recommendations: 1) If celiac disease or gluten sensitivity is suspected, consult a physician and consider a gluten-free diet. 2) Ensure adequate calcium and vitamin D intake (supplements only if needed). 3) Consider bone density screening after menopause. 4) Discuss hormone replacement therapy (HRT) individually – there is no evidence that HLA-DQ2 alters HRT efficacy. The evidence is mixed: HLA-DQ2 is well-established as a celiac risk factor, but its interaction with menopause is mechanistic and not supported by human studies. Be cautious of DNA test claims offering personalized menopause strategies.